October 13-14, 2018
New York Marriott Downtown Hotel and Conference Center
The Summit is planned in conjunction with the 10th International Workshop on WM (IWWM-10), October 11-13, 2018 where over 200 investigators from around the world are expected to attend.… Continue reading
Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc announced that the US Food and Drug Administration (FDA) has granted Priority Review for a supplemental New Drug Application (sNDA) for the company’s Waldenström’s macroglobulinemia combination therapy, ibrutinib (IMBRUVICA)… Continue reading
Cognitive Behavioural Therapy (CBT) as an aid for tackling anxiety. – Michael Collins
Cognitive Behavioural Therapy gives you quick, practical and goal-driven skills to help you tackle the acute anxiety that can come with a cancer diagnosis. It won’t… Continue reading
The following link is to the Cancer Therapy Advisor website featuring the following video
Meletios Dimopoulos, MD, discusses his findings at the ASCO 2018 meeting in Chicago.
Full link:
May 22, 2018
Decreasing the dose intensity (DI) of ibrutinib may reduce progression-free survival (PFS) among patients with Waldenstrom macroglobulinemia (WM)… Continue reading
Treatment with a combination of ibrutinib and rituximab improved progression-free survival (PFS) over rituximab alone in patients with Waldenström macroglobulinemia (WM), according to results… Continue reading
Patients with particular abnormal proteins in their blood — a condition known as monoclonal gammopathies of undetermined significance (MGUS) — have a small, but persistent lifetime risk of multiple myeloma or other… Continue reading
April 26, 2018
Ixazomib, dexamethasone, and rituximab (IDR) may be a safe and effective combination for patients with Waldenstrom macroglobulinemia (WM), according to a… Continue reading
My life so far has been an exciting journey, punctuated by a cascade of medical events. Never a dull moment. You don’t know how you’ll respond to bad news until you are faced with it. I’ve had plenty,… Continue reading
Source: https://www.indycar.com/News/2018/04/04-28-Hoosier-Park-charity-race
ANDERSON, Indiana – Verizon IndyCar Series drivers James Hinchcliffe, Alexander Rossi, Zach Veach and Robert Wickens are used to having hundreds of horsepower at their disposal on a racetrack.
Friday… Continue reading
